Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
fMRI brain network marker study in major depressive disorder with escitalopram and comparison groups
jRCTs062220063Recruiting
- Sponsor
- Japan Agency for Medical Research and Development
- Start
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of escitalopram in major depressive disorder (MDD) (4 arms), sponsored by Japan Agency for Medical Research and Development. Started Oct 2022; status: recruiting.
02
Drugs
escitalopram
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on jRCTs062220063.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs062220063.